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SUMMARY
Colorectal cancer (CRC) is one of the most common and lethal cancers in the world with over 
1.8 million newly diagnosed patients and approximately 900,000 deaths in 2018. Current 
predictions by the International Agency for Research on Cancer estimate a considerable 
increase in incidence and mortality in the upcoming decade in particular due to the aging 
population and the growing number of countries with a high human development index. Early 
detection and a better understanding of the biology of the disease will be instrumental in 
managing the growing burden of CRC.
Currently, colonoscopy and the fecal immunochemical test (FIT) are being used as tools for 
early detection of CRC. Colonoscopy is considered the gold standard for CRC detection, 
although the costs and the invasive nature of the procedure are considered as noteworthy 
limitations. Therefore, non-invasive tests such as the FIT and the Cologuard® have been 
developed, however, at present, both tests still have a suboptimal sensitivity (79-91% for 
FIT and 92.3% for Cologuard) when compared to the colonoscopy (92-99% sensitivity). 
For prognostic purposes, the tumor-lymph node-metastasis (TNM) classification is currently 
regarded as the gold standard for CRC. Nonetheless, TNM classification alone is insufficient 
in predicting prognosis as the clinical outcome can differ significantly among patients with a 
similar TNM stage. 
Previously, CRC carcinogenesis was considered to be predominantly caused by the 
accumulation of genetic alterations and/or epigenetically induced changes in driver genes 
which are able to initiate the transformation of epithelial cells towards malignant cells. In the 
last decade, it has been recognized that tumor cells are able to reciprocally interact with a 
wide variety of other cell types such as endothelial cells, pericytes, fibroblasts, immune cells 
and nerve cells, the so-called tumor-microenvironment (TME). This interaction between CRC 
cells and the TME has major functional implications allowing the tumor to progress. Though 
some cells of the TME, such as immune cells, have been extensively studied and are promising 
targets for cancer treatment, many questions remain on the biological roles of other cell types 
in the CRC TME. 
In an attempt to improve the current CRC early detection assays and the prognostic 
classification system for CRC, research continues to focus on the identification of novel 
biomarkers. Previously we identified NDRG4 DNA methylation as an early detection marker 
for colorectal cancer, which thereafter has been implemented in an FDA-approved stool DNA 
test (Cologuard®). Moreover, we found that NDRG4 is specifically expressed in the (enteric) 
nervous system (ENS). So far, no role for the ENS has been described in CRC development 
and/or progression. 
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The aim of the research described in this thesis was 1) to clarify the role of NDRG4 and the 
(enteric) neurons in CRC carcinogenesis and 2) to improve current CRC early detection and 
prognosis assessment by identifying novel diagnostic and prognostic biomarkers. 
In chapter 2, we extensively reviewed the current knowledge on the role of (enteric) neurons 
in CRC development/progression. Based on the reviewed studies, we concluded that 
perineural invasion (PNI) and (neo)neurogenesis are indicators for tumor aggressiveness and 
can act as independent prognostic factors for 5-year disease-free, cancer-specific and overall 
survival in CRC. In addition, it has been shown that neuronal innervation can promote cancer 
development in multiple cancer types (prostate, pancreatic, skin and gastric) while denervation 
can attenuate progression. Similar observations were made for the ENS specifically, where the 
loss of enteric neurons was associated with a reduced risk for CRC development indicating a 
pivotal role of ENS in CRC. Moreover, different neuromodulators can either promote or inhibit 
CRC carcinogenesis by regulating cell proliferation, migration, angiogenesis and metastasis. 
Thus, multiples lines of evidence indicate a role for neurons in CRC carcinogenesis.
We further investigated the role of the enteric neuronal protein NDRG4 in CRC in chapter 3. 
Studying a genetic model (APCMin/+) and a chemical model (azoxymethane), we observed that 
absence of NDRG4 did not alter the number of adenomas but promoted the development of 
larger intestinal adenomas with a more aggressive phenotype. Through a co-culture model, in 
which intestinal epithelial organoids were subjected to conditioned medium from NDRG4+/+ or 
NDRG4-/- primary ENS cultures, we observed that loss of NDRG4 enhanced the relative growth 
and the formation of crypt buds of the intestinal epithelial organoids. Two secreted factors, 
which also enhance CRC cell migration in vitro, were significantly enriched within the medium 
of NDRG4-/- ENS cultures as compared to NDRG4+/+ ENS cultures: nidogen-1 and fibulin-2. 
To improve the early detection of CRC, novel biomarkers that complement the current 
diagnostic tools are required. Therefore, in chapter 4, we applied an in silico biomarker 
discovery analysis using publicly available data, to identify novel diagnostic DNA methylation 
markers. 221 genes were identified as potential diagnostic biomarkers which, after confirmation 
in CRC tissue samples, resulted in the selection of 5 genes for further validation using fecal 
DNA. In stool (n = 50 normal, n = 43 carcinoma), the sensitivity of the 5 genes ranged from 31.8-
46.4% at 98.0% specificity with the combination of gene 1/gene 4 acting as the best biomarker 
panel (sensitivity: 48.8% at 98.0% specificity). Though these biomarkers by themselves do 
not outperform the current standards for CRC early detection, the diagnostic value of these 
biomarkers in combination with these standard assays (FIT, Cologuard®) is yet to be explored. 
To study the pathways that exhibited promoter methylation, we performed gene ontology 
enrichment and pathway analyses on the identified gene set (n = 221). We found that 37.0-
62.5% of all enriched biological process and 52.2-80.0% of all enriched cellular component 
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ontologies were linked with the nervous system, which was significantly higher than expected 
based on random distribution. Furthermore pathway analyses revealed that 35.0-90.9% of 
all affected pathways were associated with neurotransmitter signaling, synaptic vesicle cycle 
or axon guidance. These findings indicate that tumor cells might share characteristics with 
neuronal cells implicating an unexplored role of neuronal genes in epithelial/tumor cells and 
that these features can be exploited for improving existing early detection tests for colorectal 
cancer.
Next we explored whether the nervous system is associated with CRC prognosis by studying 
the expression of the neuronal markers neurofilament (NF) and protein gene product 9.5 
(PGP9.5) in CRC in chapter 5. CRC tissues (n = 204) were immunohistochemically stained for 
either NF or PGP9.5 and were digitally evaluated, either via random sampling or whole slide 
evaluation. Both markers were expressed in large as well as small nerve fibers located within 
the stroma of colorectal tumors. NF-positive staining was associated with a higher number 
of CRC deaths (multivariate HRNF+ = 1.93; 95%-CI: 0.92-4.06 based on whole slide evaluation). 
Similarly, PGP9.5-positivity was associated with poorer survival (multivariate HRPGP9.5 = 1.75; 
95%-CI: 0.56-5.47 based on whole slide evaluation). The combination of NF and PGP9.5 did 
not result in any statistically significant association, neither when both markers were expressed 
(pNF+/PGP9.5+ = 0.233) nor when only one of the two markers was positive (pNF or PGP9.5 = 0.318). 
Nonetheless, multivariate analysis suggested a decreased survival in patients positive for 
one or two of the markers (HRNF+/PGP9.5+ = 2.26; 95%-CI: 0.59-8.69), and HRNF or PGP9.5 = 2.01; 95%-
CI: 0.51-7.95). No statistically significant differences were observed between the evaluation 
methods. 
In chapter 6, the significance and the underlying association between the obtained results in 
this thesis were explored and discussed. Our findings and the growing amount of literature 
suggest that the (enteric) nervous system could play, a currently underestimated, pivotal 
role in the development and progression of cancer and CRC in particular. We have shown 
that disruptions in neuronal vesicle trafficking might alter the intercellular crosstalk between 
neuronal cells and tumor cells, either via changes in release of neurotransmitters but also due 
to altered secretion of other soluble factors like ECM-related proteins. Evidence collected in 
this thesis illustrates that neuronal innervation is not only limited to a biological role in CRC but 
that expression of neuronal proteins or methylation of neuronal genes are possible candidates 
for diagnostic or prognostic marker development. If both the biological and translational role 
of neuronal innervation in CRC is further explored, applications towards therapeutic options 
need to be considered for the future. 
